|
|
Article: SBIO partners on tumor biomarker research.(National University Hospital-National University of Singapore Tissue Repository)(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- June 4, 2007
CopyrightCOPYRIGHT 2007 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
S*BIO Pte, a privately-held, Singaporean biotechnology company focused on the research and clinical development of novel targeted small-molecule drugs for the treatment of cancer, has entered into a two-year research partnership with National University Hospital-National University of Singapore Tissue Repository. The company is partnering with Robert Hewitt, Director of the NUH-NUS TR, to conduct biomarker research and evaluate tumors' responsiveness to S*BIO's proprietary anticancer compounds.
"This partnership will allow us to better understand our ...